DR.PRIO Trademark

Trademark Overview


On Wednesday, October 25, 2023, a trademark application was filed for DR.PRIO with the United States Patent and Trademark Office. The USPTO has given the DR.PRIO trademark a serial number of 79384227. The federal status of this trademark filing is REGISTERED as of Tuesday, January 21, 2025. This trademark is owned by PurpleLabs HealthCare Inc.. The DR.PRIO trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceutical preparations mainly based on grain for use as a dietary supplement; nutraceutical preparations mainly based on grain for the treatment of liver disorders; nutraceutical preparations mainly based on fruits for use as a dietary supplement; nutraceutical preparations mainly based on fruits for the treatment of digestive disorders; diet capsules; nutraceutical preparations mainly based on beans for use as a dietary supplement; dietary supplements with a cosmetic effect; nutraceutical preparations mainly based on vitamins for use as a dietary supplement; nutraceutical preparations mainly based on fish for the treatment of joint diseases; dietary supplemental drinks; dietary supplements; nutraceuticals for use as a dietary supplement; nutraceutical preparations mainly based on fish and shellfish for use as a dietary supplement; nutraceutical preparations mainly based on meat for use as a dietary supplement; dietary and nutritionally fortified food products adapted for medical p...
dr.prio

General Information


Serial Number79384227
Word MarkDR.PRIO
Filing DateWednesday, October 25, 2023
Status700 - REGISTERED
Status DateTuesday, January 21, 2025
Registration Number7656502
Registration DateTuesday, January 21, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Description of MarkThe mark consists of a design of five Korean characters followed below by the stylized wording "DR.PRIO".
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "DAKTEO PEULIO" and this means "DR. PRIO" in English.
Goods and ServicesNutraceutical preparations mainly based on grain for use as a dietary supplement; nutraceutical preparations mainly based on grain for the treatment of liver disorders; nutraceutical preparations mainly based on fruits for use as a dietary supplement; nutraceutical preparations mainly based on fruits for the treatment of digestive disorders; diet capsules; nutraceutical preparations mainly based on beans for use as a dietary supplement; dietary supplements with a cosmetic effect; nutraceutical preparations mainly based on vitamins for use as a dietary supplement; nutraceutical preparations mainly based on fish for the treatment of joint diseases; dietary supplemental drinks; dietary supplements; nutraceuticals for use as a dietary supplement; nutraceutical preparations mainly based on fish and shellfish for use as a dietary supplement; nutraceutical preparations mainly based on meat for use as a dietary supplement; dietary and nutritionally fortified food products adapted for medical purposes; multivitamin preparations; nutraceutical preparations mainly based on tea for use as a dietary supplement; nutraceutical preparations mainly based on vegetables for use as a dietary supplement; health food supplements for persons with special dietary requirements; anti-oxidant food supplements; nutraceutical preparations mainly based on seaweeds for use as a dietary supplement; nutraceutical preparations mainly based on red ginsengs for use as a dietary supplement

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePurpleLabs HealthCare Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NamePurpleLabs HealthCare Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NamePurpleLabs HealthCare Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 15, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 5, 2023APPLICATION FILING RECEIPT MAILED
Saturday, May 25, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 7, 2024ASSIGNED TO EXAMINER
Monday, June 10, 2024NON-FINAL ACTION WRITTEN
Saturday, June 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 29, 2024REFUSAL PROCESSED BY MPU
Tuesday, October 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 20, 2024REFUSAL PROCESSED BY IB
Tuesday, October 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, April 21, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 29, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 29, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, May 17, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, January 21, 2025REGISTERED-PRINCIPAL REGISTER
Monday, August 4, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 22, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 4, 2025FINAL DISPOSITION PROCESSED